Figure 3 showed that the immune scores of the patients had no statistically relevant correlation with the following clinical features: gender (p = .94), age (p = .45), primary tumor site (p = .60), microsatellite unstable state (p = .59), the KRAS gene mutation state (p = .61), serum CEA level (p = .28). Here, KRAS is linked to neoplasm.